Tecella

What Tecella does

Tecella is a privately held scientific instrumentation company headquartered in Foothill Ranch, California. Founded in 2007 and operating with a team of 1-10 employees, the company designs and manufactures patch clamp amplifiers and multi-electrode array (MEA) amplifiers, along with the supporting software required to operate these instruments and analyze the resulting electrophysiological data. Its products serve the ion channel research and drug discovery communities — principally academic neuroscience and cardiac safety laboratories, and pharmaceutical/biotech R&D groups conducting electrophysiology-based screening and basic research on excitable cells.

The company's core technical offering sits at the analog front end of cellular electrophysiology: precision, low-noise current/voltage amplification hardware that resolves picoampere-scale signals from individual cells or populations of cells, paired with acquisition and analysis software. Patch clamp amplifiers support single-cell voltage- and current-clamp recordings (the gold-standard technique for ion channel characterization), while MEA amplifiers enable parallel extracellular recording from networks of cells across multi-well plates — a configuration commonly used in cardiac safety pharmacology and neural network assays. No AI/ML-driven analytics features are evidenced in the current product surface.

Revenue mechanics are consistent with a niche, high-ASP capital equipment vendor: small unit volumes, direct or distributor-led sales to research institutions and pharmaceutical laboratories, and likely service/software attach revenue. The firm has operated without disclosed external funding rounds, suggesting organic, cash-flow-funded operations over its 17-year history. Source data for the company's own web properties was inaccessible (loading/verification page) at time of extraction, so deeper product, pricing, customer, and partnership details are not verifiable from the present dataset.

Name

Tecella

Website

https://tecella.com

Company type

Private

Founded year

2007

Headcount range

1–10 employees

Short description

Tecella, founded in 2007 and based in Foothill Ranch, California, manufactures patch clamp and multi-electrode array (MEA) amplifiers with supporting software for electrophysiology research and drug discovery, serving academic and pharmaceutical laboratories.

Ownership category

akta.pro rank

Product category

Electrophysiology Instrumentation

NAICS

Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)

SIC

Instruments For Meas & Testing Of Electricity & Elec Signals (3825), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Amplifiers & Comparators (HDAHAIAC)

akta.pro secondary industry

Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration) (HDAHALAO)

Keywords

• Patch clamp amplifiers
• MEA amplifiers
• Electrophysiology instruments
• Drug discovery tools
• Neuroscience instrumentation

Headquarters

HQ city

Foothill Ranch

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations

Core offering

Tecella designs, manufactures, and sells patch clamp amplifiers and microelectrode array (MEA) amplifiers used in electrophysiology research. The company also provides supporting software that operates with its amplifiers to capture and analyze cellular electrical signals for life science and drug discovery applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Patch Clamp Amplifiers Electronic amplifier instruments that measure ion channel currents and cellular electrical activity from single cells or excised patches, used by electrophysiology researchers in academic and pharmaceutical laboratories.
• MEA Amplifiers Microelectrode array amplifiers that record extracellular electrical activity from networks of cells, used in neuroscience and cardiotoxicity screening for drug discovery research.
• Supporting Acquisition and Analysis Software Companion software that interfaces with Tecella amplifiers to control data acquisition and analyze recorded electrophysiology signals for research and drug discovery workflows.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Sophion Bioscience: Sophion Bioscience focuses on automated patch clamp platforms (QPatch) for ion channel drug discovery and safety screening. It addresses a similar electrophysiology customer base as Tecella but emphasizes high-throughput automated systems rather than traditional benchtop amplifiers.

Direct peers

• Warner Instruments (Harvard Bioscience): Warner Instruments, a Harvard Bioscience brand, supplies patch clamp amplifiers, electrodes, and perfusion systems used in classical electrophysiology. It competes with Tecella in patch clamp amplification for academic and research labs.
• Axion Biosystems: Axion Biosystems specializes in MEA-based electrophysiology platforms such as the Maestro system for cardiac and neural recording. It directly competes with Tecella in the MEA amplifier segment and serves similar academic, pharma, and drug safety screening customers.
• NPI Electronic: NPI Electronic is a German manufacturer of patch clamp amplifiers (e.g., SEC-05LX, EPC-10 variants) and signal conditioning electronics for electrophysiology. It is a direct small/mid-sized peer to Tecella in amplifier-based electrophysiology recording.
• HEKA Elektronik: HEKA Elektronik designs and manufactures high-quality patch clamp amplifiers (EPC series) and acquisition software widely used in academic electrophysiology. It is one of the closest direct competitors to Tecella's patch clamp amplifier product line.
• Nanion Technologies: Nanion Technologies is a specialist in automated patch clamp (Port-a-Patch, Patchliner, SyncroPatch) and MEA (CardioExcyte) electrophysiology platforms. It is a direct peer to Tecella across both product categories and competes strongly in ion channel drug discovery.
• Multi Channel Systems (MCS) / Harvard Bioscience: Multi Channel Systems is a leading manufacturer of microelectrode array (MEA) recording systems and amplifiers, now part of Harvard Bioscience. It is the most direct competitor to Tecella's MEA amplifier product line and serves overlapping electrophysiology and neuroscience research customers.

Broad incumbents

• Molecular Devices: Molecular Devices (a Danaher operating company) is a major incumbent in electrophysiology and is best known for its PatchMaster-based patch clamp amplifier systems and multi-well automated electrophysiology platforms. It directly competes with Tecella's patch clamp amplifier offering while also offering a much broader portfolio of life science instruments.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/tecella

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tecella